Peripheral and Central miRNA Signatures in Alzheimer’s Disease: Tissue-Specific Variability, Sex-Associated Differences, and Implications for Blood-Based Biomarkers
International Journal of Molecular Sciences · 03.07.2026 · 27 (13) · 5990
DOI: 10.3390/ijms27135990 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 03.07.2026. Verfasst von Amy S Shiyab und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Sciences, Kent State University, Kent, OH 44140, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, MicroRNAs, Biomarkers. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 484 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NIH HHS, National Institutes of Health.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline and significant neuropathological changes. Early and accurate diagnosis remains a major challenge, highlighting the need for reliable, minimally invasive biomarkers. MicroRNAs (miRNAs), small non-coding RNAs that regulate gene expression, have emerged as promising candidates. Their expression is altered in the brains of AD patients, reflecting disease-specific pathological processes, and they are detectable in peripheral biofluids. However, discrepancies in miRNA profiles between the brain and the circulation, and between patient populations remain a significant limitation, raising questions about their origin, transport across the blood–brain barrier, and their reliability in reflecting central nervous system pathology. This review provides a comprehensive overview of current research comparing miRNA expression profiles in brain tissue and blood in AD, with a focus on their biological relevance, mechanisms of release and transport, and diagnostic potential. We also discuss the challenges associated with cross-tissue variability, methodological inconsistencies, and the need for standardized approaches. Finally, we highlight future directions, including multi-tissue analyses and integration with other noninvasive modalities, to improve the clinical utility of miRNA-based biomarkers in AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biomedical Sciences, Kent State University, Kent, OH 44140, USA.
- Department of Pharmaceutical Sciences, Northeast Ohio Medical University, Rootstown, OH 44242, USA.
ORCID-Profile: Erin G Reed
Förderung
- NIA NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Shiyab, A. S., & Reed, E. G. (2026). Peripheral and Central miRNA Signatures in Alzheimer’s Disease: Tissue-Specific Variability, Sex-Associated Differences, and Implications for Blood-Based Biomarkers. International Journal of Molecular Sciences, 27(13), 5990. https://doi.org/10.3390/ijms27135990
Vancouver
Shiyab AS, Reed EG. Peripheral and Central miRNA Signatures in Alzheimer’s Disease: Tissue-Specific Variability, Sex-Associated Differences, and Implications for Blood-Based Biomarkers. International Journal of Molecular Sciences. 2026;27(13):5990. doi:10.3390/ijms27135990
BibTeX
@article{Shiyab2026,
author = {Shiyab, Amy S and Reed, Erin G},
title = {Peripheral and Central miRNA Signatures in Alzheimer’s Disease: Tissue-Specific Variability, Sex-Associated Differences, and Implications for Blood-Based Biomarkers},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {13},
pages = {5990},
doi = {10.3390/ijms27135990}
}
EUVIMED